Market Access Strategy for Med Tech Companies in Europe

The reimbursement strategy answers the question of how reimbursement can be established or improved for medical technology

The market access strategy is always based on the results of a comprehensive reimbursement analysis (procedure coding, payment mechanism, tariffs, policy, and Health Technology Assessment considerations).

Multiple situations may call for reimbursement strategy support, for example:

Technology is new and no coding and reimbursement are available
Coding and reimbursement are available, but the tariff is low and does not cover the cost of a device
Coding and reimbursement are available, and the tariff is sufficient, but there are restrictions on the target population for the procedure

The market access strategy includes an understanding of the relevant pathways (including innovative payment schemes), stakeholders involved, the process, data and evidence requirements, timelines, and deadlines for applications.

What is Included in the Scope?

MTRC is the leader in reimbursement analysis and strategy for medical technologies in Europe. We provide services to most major corporations, numerous small- and medium-sized enterprises, as well as other life sciences consulting companies. Over many years of practice, MTRC has developed a robust analytical and reporting methodology that answers all your key questions.

The typical scope of the reimbursement strategy project includes:

Problem statement

A clear outline of the market access problems on the market

Ultimate market access goal and key pathways

Ultimate (final) market access objective on the market
Coding and reimbursement, funding, HTA, and innovative payment pathways
Key steps in each process

Stakeholders involved

Applicants, appraising bodies, decision-makers, and decision-influencers

Data and evidence requirements

Specifics of the submission template
Evidence requirements for the process

Timelines and deadlines

Deadlines for applications and timelines for each pathway

The pre-requisite for the majority of the strategy projects is the availability of good information about the current reimbursement situation for a procedure or device: procedure coding, payment mechanism, reimbursement tariffs, policy, and HTA considerations. MTRC provides a service of reimbursement analysis in 14 European countries.

Get insights From MTRC Free Analytical Reports

Explore free MTRC analytical reports and white papers for in-depth insights into reimbursement for medical technologies in Europe

Explore MTRC research papers:

Explore more white papers

How Does MTRC Perform the Analysis and Ensure High Quality of Work?

In order to deliver analysis in multiple and very diverse EU markets, we employ a number of approaches:

We secure access to necessary coding/grouping software and documentation.

In many countries, the software for DRG analysis is only available at a significant cost or available only to hospital providers. We make sure that necessary tools are at our disposal for analysis

We developed know-how of reimbursement analysis in EU markets over many years of consulting practice.

While there are certain general patterns of analysis, which are the same for any system, each country is unique, and a true understanding of the market comes only with the experience

We became a highly standardized organization to ensure the high quality of our work.

We maintain Work Instructions in every country to train new analysts, checklists for daily work, necessary processes, and meetings to learn from mistakes and share knowledge within the organization. We are an ISO 9001:2015 certified organization (with the United Kingdom Accreditation Service, UKAS), which confirms the existence of well-structured processes of quality management

We stay up to date about developments in key markets through our unique paid subscription services Reimbursement and HTA Alerts

We are usually the first to learn about new developments, including procedure coding, payment mechanisms, policies, HTA landscape in general and in relation to individual technologies. We monitor more than 50 organizations every two weeks and more than 200 organizations annually to have a good understanding of all changes in the payment systems

Market Access Strategy for Medical Devices in Europe